DIWALI SPECIAL

25% OFF + 1-Yr NT Prime FREE !

Use
00h : 00m : 00s
Claim Offer →
logo

HINDCON vs SUDARSHAN: Stock Comparison

HINDCON vs SUDARSHAN PHARMA INDUpdated 1 Oct 26, 4:08 PM ISTNSE & company filings

HINDCON shows faster revenue growth and a higher net margin, while SUDARSHAN PHARMA IND shows a lower P/E. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

HINDCON leads 3; SUDARSHAN leads 5 of 9

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

HINDCONSUDARSHAN

Valuation lens

What price are you paying?

Market CapContext only
₹141 Cr
₹0 Cr
P/E RatioSUDARSHAN has the lower reading
38.38x
28.27x ✓
P/B RatioHINDCON has the lower reading
0x ✓
4.11x
EPSSUDARSHAN has the higher reading
₹0.27
₹0.32 ✓
Book ValueContext only
₹11.35
₹6.14
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

P/E Ratio
SUDARSHAN has a lower P/E
28.27x vs 38.38x
P/B Ratio
HINDCON has a lower P/B
0x vs 4.11x
EPS
SUDARSHAN has higher earnings per share
₹0.32 vs ₹0.27
Revenue Growth (TTM YoY)
HINDCON has faster revenue growth
7.9% vs 0%
EPS Growth (TTM YoY)
SUDARSHAN has faster EPS growth
0% vs -42.43%
Qtr Sales Growth
SUDARSHAN has stronger quarterly sales growth
24.4% vs 3.23%
Qtr Profit Growth
SUDARSHAN has stronger quarterly profit growth
38.7% vs -47.22%
Net Margin
HINDCON has a higher net margin
4.74% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricHINDCONSUDARSHAN
SectorChemicals—
IndustrySpecialty Chemicals—

Price

MetricHINDCONSUDARSHAN
Live Price₹33.3₹32.71
Day Change-4.99%0.03%
Volume73,53792,985
52-Week High₹35.05₹39.3
52-Week Low₹15.66₹31.01
Distance from 52W High-4.99%-16.77%

Valuation

MetricHINDCONSUDARSHAN
Market Cap₹141 Cr₹0 Cr
P/E Ratio38.38x28.27x
P/B Ratio0x4.11x
EPS₹0.27₹0.32
Book Value₹11.35₹6.14
Dividend Yield0%0%

Growth

MetricHINDCONSUDARSHAN
Revenue Growth (TTM YoY)7.9%0%
EPS Growth (TTM YoY)-42.43%0%
Qtr Sales Growth3.23%24.4%
Qtr Profit Growth-47.22%38.7%

Profitability & Leverage

MetricHINDCONSUDARSHAN
ROE5.3%—
ROCE5.57%—
Net Margin4.74%0%
Operating Margin7.5%—
Debt to Equity0.19x—

Shareholding

As of Sep 2026 • change vs previous quarter
MetricHINDCONSUDARSHAN
Promoter Holding69.02%▲ 0.21 pp57.81%▼ 1.12 pp
FII Holding0%21.95%▲ 2.57 pp
DII Holding0%0%
Public Holding30.98%▼ 0.21 pp20.19%▼ 1.45 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: HINDCON and SUDARSHAN PHARMA IND.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.